CompletedNCT00227123
Quetiapine or risperidone for mood symptoms and stimulant use in bipolarity
About this title
A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder With Stimulant Dependence
Read the official source — NCT00227123Medication studyAges 20–50United States
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 20 years to 50 years. Other eligibility criteria applied.
- Listed locations
- Dallas and 1 more locationSee all locations and recruitment
Study information
Study start dateOctober 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 96
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 20 Years to 50 Years
- Official registry ID
- NCT00227123
- Official title
Show the full official title
A Randomized Control Trial Comparing Quetiapine to Risperidone in Bipolar Disorder Outpatients With Current Stimulant Dependence
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas · Fort Worth
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including quetiapine, risperidone.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 20 years to 50 years. Other eligibility criteria applied.
